283 related articles for article (PubMed ID: 19075186)
1. Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL.
Gordon WR; Roy M; Vardar-Ulu D; Garfinkel M; Mansour MR; Aster JC; Blacklow SC
Blood; 2009 Apr; 113(18):4381-90. PubMed ID: 19075186
[TBL] [Abstract][Full Text] [Related]
2. Effects of S1 cleavage on the structure, surface export, and signaling activity of human Notch1 and Notch2.
Gordon WR; Vardar-Ulu D; L'Heureux S; Ashworth T; Malecki MJ; Sanchez-Irizarry C; McArthur DG; Histen G; Mitchell JL; Aster JC; Blacklow SC
PLoS One; 2009 Aug; 4(8):e6613. PubMed ID: 19701457
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Notch1 antibodies that inhibit signaling of both normal and mutated Notch1 receptors.
Aste-Amézaga M; Zhang N; Lineberger JE; Arnold BA; Toner TJ; Gu M; Huang L; Vitelli S; Vo KT; Haytko P; Zhao JZ; Baleydier F; L'Heureux S; Wang H; Gordon WR; Thoryk E; Andrawes MB; Tiyanont K; Stegmaier K; Roti G; Ross KN; Franlin LL; Wang H; Wang F; Chastain M; Bett AJ; Audoly LP; Aster JC; Blacklow SC; Huber HE
PLoS One; 2010 Feb; 5(2):e9094. PubMed ID: 20161710
[TBL] [Abstract][Full Text] [Related]
4. Force-induced unfolding simulations of the human Notch1 negative regulatory region: possible roles of the heterodimerization domain in mechanosensing.
Chen J; Zolkiewska A
PLoS One; 2011; 6(7):e22837. PubMed ID: 21829530
[TBL] [Abstract][Full Text] [Related]
5. Direct observation of proteolytic cleavage at the S2 site upon forced unfolding of the Notch negative regulatory region.
Stephenson NL; Avis JM
Proc Natl Acad Sci U S A; 2012 Oct; 109(41):E2757-65. PubMed ID: 23011796
[TBL] [Abstract][Full Text] [Related]
6. Human NOTCH2 Is Resistant to Ligand-independent Activation by Metalloprotease Adam17.
Habets RA; Groot AJ; Yahyanejad S; Tiyanont K; Blacklow SC; Vooijs M
J Biol Chem; 2015 Jun; 290(23):14705-16. PubMed ID: 25918160
[TBL] [Abstract][Full Text] [Related]
7. Leukemia-associated mutations within the NOTCH1 heterodimerization domain fall into at least two distinct mechanistic classes.
Malecki MJ; Sanchez-Irizarry C; Mitchell JL; Histen G; Xu ML; Aster JC; Blacklow SC
Mol Cell Biol; 2006 Jun; 26(12):4642-51. PubMed ID: 16738328
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for autoinhibition of Notch.
Gordon WR; Vardar-Ulu D; Histen G; Sanchez-Irizarry C; Aster JC; Blacklow SC
Nat Struct Mol Biol; 2007 Apr; 14(4):295-300. PubMed ID: 17401372
[TBL] [Abstract][Full Text] [Related]
9. Insights into Autoregulation of Notch3 from Structural and Functional Studies of Its Negative Regulatory Region.
Xu X; Choi SH; Hu T; Tiyanont K; Habets R; Groot AJ; Vooijs M; Aster JC; Chopra R; Fryer C; Blacklow SC
Structure; 2015 Jul; 23(7):1227-35. PubMed ID: 26051713
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic antibody targeting of individual Notch receptors.
Wu Y; Cain-Hom C; Choy L; Hagenbeek TJ; de Leon GP; Chen Y; Finkle D; Venook R; Wu X; Ridgway J; Schahin-Reed D; Dow GJ; Shelton A; Stawicki S; Watts RJ; Zhang J; Choy R; Howard P; Kadyk L; Yan M; Zha J; Callahan CA; Hymowitz SG; Siebel CW
Nature; 2010 Apr; 464(7291):1052-7. PubMed ID: 20393564
[TBL] [Abstract][Full Text] [Related]
11. Notch in Leukemia.
McCarter AC; Wang Q; Chiang M
Adv Exp Med Biol; 2018; 1066():355-394. PubMed ID: 30030836
[TBL] [Abstract][Full Text] [Related]
12. Evidence for increased exposure of the Notch1 metalloprotease cleavage site upon conversion to an activated conformation.
Tiyanont K; Wales TE; Aste-Amezaga M; Aster JC; Engen JR; Blacklow SC
Structure; 2011 Apr; 19(4):546-54. PubMed ID: 21481777
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of the Notch2 negative regulatory region identifies key structural elements for mechanical stability.
Stephenson NL; Avis JM
FEBS Open Bio; 2015; 5():625-33. PubMed ID: 26288744
[TBL] [Abstract][Full Text] [Related]
14. A novel Monoclonal Antibody against Notch1 Targets Leukemia-associated Mutant Notch1 and Depletes Therapy Resistant Cancer Stem Cells in Solid Tumors.
Sharma A; Gadkari RA; Ramakanth SV; Padmanabhan K; Madhumathi DS; Devi L; Appaji L; Aster JC; Rangarajan A; Dighe RR
Sci Rep; 2015 Jun; 5():11012. PubMed ID: 26046801
[TBL] [Abstract][Full Text] [Related]
15. Deletion-based mechanisms of Notch1 activation in T-ALL: key roles for RAG recombinase and a conserved internal translational start site in Notch1.
Ashworth TD; Pear WS; Chiang MY; Blacklow SC; Mastio J; Xu L; Kelliher M; Kastner P; Chan S; Aster JC
Blood; 2010 Dec; 116(25):5455-64. PubMed ID: 20852131
[TBL] [Abstract][Full Text] [Related]
16. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
[TBL] [Abstract][Full Text] [Related]
17. An activating intragenic deletion in NOTCH1 in human T-ALL.
Haydu JE; De Keersmaecker K; Duff MK; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Ferrando A
Blood; 2012 May; 119(22):5211-4. PubMed ID: 22510873
[TBL] [Abstract][Full Text] [Related]
18. Two novel protein
Takeuchi H; Schneider M; Williamson DB; Ito A; Takeuchi M; Handford PA; Haltiwanger RS
Proc Natl Acad Sci U S A; 2018 Sep; 115(36):E8395-E8402. PubMed ID: 30127001
[TBL] [Abstract][Full Text] [Related]
19. Characterization of transgenic mice expressing cancer-associated variants of human NOTCH1.
Berquam-Vrieze KE; Swing DA; Tessarollo L; Dupuy AJ
Genesis; 2012 Feb; 50(2):112-8. PubMed ID: 21898766
[TBL] [Abstract][Full Text] [Related]
20. High-resolution crystal structure of the human Notch 1 ankyrin domain.
Ehebauer MT; Chirgadze DY; Hayward P; Martinez Arias A; Blundell TL
Biochem J; 2005 Nov; 392(Pt 1):13-20. PubMed ID: 16011479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
